Healthcare provider profile · identity verified

Jeremy Daniel Defoe, D.O.

Family Practice · SAINT LOUIS, MO · NPI 1225393739

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	587	172
Amlodipine Besylate	Amlodipine Besylate	464	135
Levothyroxine Sodium	Levothyroxine Sodium	390	106
Losartan Potassium	Losartan Potassium	324	90
Lisinopril	Lisinopril	317	88
Rosuvastatin Calcium	Rosuvastatin Calcium	247	78
Omeprazole	Omeprazole	223	64
Metoprolol Succinate	Metoprolol Succinate	219	64
Pantoprazole Sodium	Pantoprazole Sodium	192	64
Gabapentin	Gabapentin	181	51
Hydrochlorothiazide	Hydrochlorothiazide	180	53
Simvastatin	Simvastatin	169	45
Tamsulosin Hcl	Tamsulosin Hcl	161	43
Sertraline Hcl	Sertraline Hcl	155	46
Metformin Hcl	Metformin Hcl	151	41
Furosemide	Furosemide	126	40
Trazodone Hcl	Trazodone Hcl	120	39
Alprazolam	Alprazolam	117	32
Montelukast Sodium	Montelukast Sodium	111	27
Eliquis	Apixaban	109	28
Carvedilol	Carvedilol	101	28
Meloxicam	Meloxicam	100	27
Escitalopram Oxalate	Escitalopram Oxalate	98	31
Zolpidem Tartrate	Zolpidem Tartrate	96	17
Pravastatin Sodium	Pravastatin Sodium	92	27
Finasteride	Finasteride	79	17
Potassium Chloride	Potassium Chloride	75	26
Allopurinol	Allopurinol	73	22
Duloxetine Hcl	Duloxetine Hcl	71	20
Spironolactone	Spironolactone	70	18
Albuterol Sulfate Hfa	Albuterol Sulfate	67	30
Ipratropium Bromide	Ipratropium Bromide	67	25
Metoprolol Tartrate	Metoprolol Tartrate	64	19
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	62	15
Metformin Hcl Er	Metformin Hcl	61	23
Bupropion Xl	Bupropion Hcl	55	16
Fluticasone Propionate	Fluticasone Propionate	55	23
Glipizide	Glipizide	54	15
Clopidogrel	Clopidogrel Bisulfate	53	16
Atenolol	Atenolol	50	11
Famotidine	Famotidine	49	16
Farxiga	Dapagliflozin Propanediol	49	11
Irbesartan	Irbesartan	48	15
Prednisone	Prednisone	48	32
Citalopram Hbr	Citalopram Hydrobromide	45	13
Tramadol Hcl	Tramadol Hcl	45	18
Isosorbide Mononitrate Er	Isosorbide Mononitrate	41	11
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	41	14
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	39	15
Mounjaro	Tirzepatide	39	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	38	12
Synthroid	Levothyroxine Sodium	38	13
Lovastatin	Lovastatin	36	11
Propranolol Hcl	Propranolol Hcl	35	12
Ropinirole Hcl	Ropinirole Hcl	35	suppressed
Xarelto	Rivaroxaban	35	suppressed
Lorazepam	Lorazepam	32	suppressed
Clonazepam	Clonazepam	30	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	30	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	29	27
Ezetimibe	Ezetimibe	29	suppressed
Hydralazine Hcl	Hydralazine Hcl	29	12
Tizanidine Hcl	Tizanidine Hcl	28	11
Amiodarone Hcl	Amiodarone Hcl	27	suppressed
Diazepam	Diazepam	27	11
Amitriptyline Hcl	Amitriptyline Hcl	25	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	25	25
Arexvy	Rsvpref3 Antigen/As01e/Pf	25	25
Chlorthalidone	Chlorthalidone	25	suppressed
Jardiance	Empagliflozin	25	suppressed
Trulicity	Dulaglutide	25	suppressed
Valacyclovir	Valacyclovir Hcl	24	12
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	23	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	23	suppressed
Benazepril Hcl	Benazepril Hcl	22	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	22	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	22	suppressed
Ozempic	Semaglutide	22	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	22	suppressed
Fluconazole	Fluconazole	21	17
Paxlovid	Nirmatrelvir/Ritonavir	21	21
Fenofibrate	Fenofibrate	20	suppressed
Ibuprofen	Ibuprofen	20	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	20	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	19	suppressed
Dilt-Xr	Diltiazem Hcl	19	suppressed
Glipizide Er	Glipizide	18	suppressed
Januvia	Sitagliptin Phosphate	18	suppressed
Paroxetine Hcl	Paroxetine Hcl	18	suppressed
Buspirone Hcl	Buspirone Hcl	17	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	17	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	17	14
Doxycycline Hyclate	Doxycycline Hyclate	16	14
Venlafaxine Hcl Er	Venlafaxine Hcl	16	suppressed
Bupropion Hcl	Bupropion Hcl	15	suppressed
Azithromycin	Azithromycin	14	13
Baclofen	Baclofen	14	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	14	suppressed
Naproxen	Naproxen	14	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	14	suppressed
Cefdinir	Cefdinir	13	12
Doxazosin Mesylate	Doxazosin Mesylate	13	suppressed
Humulin R	Insulin Regular, Human	13	suppressed
Telmisartan	Telmisartan	13	suppressed
Benicar Hct	Olmesartan/Hydrochlorothiazide	12	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	12	suppressed
Felodipine Er	Felodipine	12	suppressed
Mirtazapine	Mirtazapine	12	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	12	suppressed
Oxazepam	Oxazepam	12	suppressed
Oxycodone Hcl	Oxycodone Hcl	12	suppressed
Valsartan	Valsartan	12	suppressed
Alendronate Sodium	Alendronate Sodium	11	suppressed
Arnuity Ellipta	Fluticasone Furoate	11	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	11	suppressed
Labetalol Hcl	Labetalol Hcl	11	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	11	suppressed
Nystatin	Nystatin	11	suppressed
Ondansetron Odt	Ondansetron	11	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	11	suppressed
Vitamin D2	Ergocalciferol (Vitamin D2)	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error